Global Hemophilia A Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Hemophilia A Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Hemophilia A Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Hemophilia A Drug by Country/Region, 2017, 2022 & 2028

2.2 Hemophilia A Drug Segment by Type

2.2.1 ATXF-8117

2.2.2 BAY-1093884

2.2.3 BIVV-001

2.2.4 BS-027125

2.2.5 Concizumab

2.2.6 CSL-689

2.2.7 Others

2.3 Hemophilia A Drug Sales by Type

2.3.1 Global Hemophilia A Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Hemophilia A Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Hemophilia A Drug Sale Price by Type (2017-2022)

2.4 Hemophilia A Drug Segment by Application

2.4.1 Clinic

2.4.2 Hospital

2.4.3 ASCs

2.5 Hemophilia A Drug Sales by Application

2.5.1 Global Hemophilia A Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Hemophilia A Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Hemophilia A Drug Sale Price by Application (2017-2022)

3 Global Hemophilia A Drug by Company

3.1 Global Hemophilia A Drug Breakdown Data by Company

3.1.1 Global Hemophilia A Drug Annual Sales by Company (2020-2022)

3.1.2 Global Hemophilia A Drug Sales Market Share by Company (2020-2022)

3.2 Global Hemophilia A Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Hemophilia A Drug Revenue by Company (2020-2022)

3.2.2 Global Hemophilia A Drug Revenue Market Share by Company (2020-2022)

3.3 Global Hemophilia A Drug Sale Price by Company

3.4 Key Manufacturers Hemophilia A Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Hemophilia A Drug Product Location Distribution

3.4.2 Players Hemophilia A Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Hemophilia A Drug by Geographic Region

4.1 World Historic Hemophilia A Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Hemophilia A Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Hemophilia A Drug Annual Revenue by Geographic Region

4.2 World Historic Hemophilia A Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Hemophilia A Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Hemophilia A Drug Annual Revenue by Country/Region

4.3 Americas Hemophilia A Drug Sales Growth

4.4 APAC Hemophilia A Drug Sales Growth

4.5 Europe Hemophilia A Drug Sales Growth

4.6 Middle East & Africa Hemophilia A Drug Sales Growth

5 Americas

5.1 Americas Hemophilia A Drug Sales by Country

5.1.1 Americas Hemophilia A Drug Sales by Country (2017-2022)

5.1.2 Americas Hemophilia A Drug Revenue by Country (2017-2022)

5.2 Americas Hemophilia A Drug Sales by Type

5.3 Americas Hemophilia A Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Hemophilia A Drug Sales by Region

6.1.1 APAC Hemophilia A Drug Sales by Region (2017-2022)

6.1.2 APAC Hemophilia A Drug Revenue by Region (2017-2022)

6.2 APAC Hemophilia A Drug Sales by Type

6.3 APAC Hemophilia A Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Hemophilia A Drug by Country

7.1.1 Europe Hemophilia A Drug Sales by Country (2017-2022)

7.1.2 Europe Hemophilia A Drug Revenue by Country (2017-2022)

7.2 Europe Hemophilia A Drug Sales by Type

7.3 Europe Hemophilia A Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Hemophilia A Drug by Country

8.1.1 Middle East & Africa Hemophilia A Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Hemophilia A Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Hemophilia A Drug Sales by Type

8.3 Middle East & Africa Hemophilia A Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Hemophilia A Drug

10.3 Manufacturing Process Analysis of Hemophilia A Drug

10.4 Industry Chain Structure of Hemophilia A Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Hemophilia A Drug Distributors

11.3 Hemophilia A Drug Customer

12 World Forecast Review for Hemophilia A Drug by Geographic Region

12.1 Global Hemophilia A Drug Market Size Forecast by Region

12.1.1 Global Hemophilia A Drug Forecast by Region (2023-2028)

12.1.2 Global Hemophilia A Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Hemophilia A Drug Forecast by Type

12.7 Global Hemophilia A Drug Forecast by Application

13 Key Players Analysis

13.1 Bayer AG

13.1.1 Bayer AG Company Information

13.1.2 Bayer AG Hemophilia A Drug Product Offered

13.1.3 Bayer AG Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer AG Main Business Overview

13.1.5 Bayer AG Latest Developments

13.2 BioMarin Pharmaceutical Inc

13.2.1 BioMarin Pharmaceutical Inc Company Information

13.2.2 BioMarin Pharmaceutical Inc Hemophilia A Drug Product Offered

13.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 BioMarin Pharmaceutical Inc Main Business Overview

13.2.5 BioMarin Pharmaceutical Inc Latest Developments

13.3 Bioverativ Inc

13.3.1 Bioverativ Inc Company Information

13.3.2 Bioverativ Inc Hemophilia A Drug Product Offered

13.3.3 Bioverativ Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bioverativ Inc Main Business Overview

13.3.5 Bioverativ Inc Latest Developments

13.4 Catalyst Biosciences Inc

13.4.1 Catalyst Biosciences Inc Company Information

13.4.2 Catalyst Biosciences Inc Hemophilia A Drug Product Offered

13.4.3 Catalyst Biosciences Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Catalyst Biosciences Inc Main Business Overview

13.4.5 Catalyst Biosciences Inc Latest Developments

13.5 Chugai Pharmaceutical Co Ltd

13.5.1 Chugai Pharmaceutical Co Ltd Company Information

13.5.2 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product Offered

13.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Chugai Pharmaceutical Co Ltd Main Business Overview

13.5.5 Chugai Pharmaceutical Co Ltd Latest Developments

13.6 CSL Ltd

13.6.1 CSL Ltd Company Information

13.6.2 CSL Ltd Hemophilia A Drug Product Offered

13.6.3 CSL Ltd Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 CSL Ltd Main Business Overview

13.6.5 CSL Ltd Latest Developments

13.7 DBV Technologies SA

13.7.1 DBV Technologies SA Company Information

13.7.2 DBV Technologies SA Hemophilia A Drug Product Offered

13.7.3 DBV Technologies SA Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 DBV Technologies SA Main Business Overview

13.7.5 DBV Technologies SA Latest Developments

13.8 Dimension Therapeutics Inc

13.8.1 Dimension Therapeutics Inc Company Information

13.8.2 Dimension Therapeutics Inc Hemophilia A Drug Product Offered

13.8.3 Dimension Therapeutics Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Dimension Therapeutics Inc Main Business Overview

13.8.5 Dimension Therapeutics Inc Latest Developments

13.9 EpiVax Inc

13.9.1 EpiVax Inc Company Information

13.9.2 EpiVax Inc Hemophilia A Drug Product Offered

13.9.3 EpiVax Inc Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 EpiVax Inc Main Business Overview

13.9.5 EpiVax Inc Latest Developments

13.10 Expression Therapeutics LLC

13.10.1 Expression Therapeutics LLC Company Information

13.10.2 Expression Therapeutics LLC Hemophilia A Drug Product Offered

13.10.3 Expression Therapeutics LLC Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Expression Therapeutics LLC Main Business Overview

13.10.5 Expression Therapeutics LLC Latest Developments

13.11 Green Cross Corp

13.11.1 Green Cross Corp Company Information

13.11.2 Green Cross Corp Hemophilia A Drug Product Offered

13.11.3 Green Cross Corp Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Green Cross Corp Main Business Overview

13.11.5 Green Cross Corp Latest Developments

13.12 Idogen AB

13.12.1 Idogen AB Company Information

13.12.2 Idogen AB Hemophilia A Drug Product Offered

13.12.3 Idogen AB Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Idogen AB Main Business Overview

13.12.5 Idogen AB Latest Developments

13.13 Immusoft Corp

13.13.1 Immusoft Corp Company Information

13.13.2 Immusoft Corp Hemophilia A Drug Product Offered

13.13.3 Immusoft Corp Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Immusoft Corp Main Business Overview

13.13.5 Immusoft Corp Latest Developments

13.14 LFB SA

13.14.1 LFB SA Company Information

13.14.2 LFB SA Hemophilia A Drug Product Offered

13.14.3 LFB SA Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 LFB SA Main Business Overview

13.14.5 LFB SA Latest Developments

13.15 mAbxience SA

13.15.1 mAbxience SA Company Information

13.15.2 mAbxience SA Hemophilia A Drug Product Offered

13.15.3 mAbxience SA Hemophilia A Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 mAbxience SA Main Business Overview

13.15.5 mAbxience SA Latest Developments

14 Research Findings and Conclusion

Table 1. Hemophilia A Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Hemophilia A Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of ATXF-8117

Table 4. Major Players of BAY-1093884

Table 5. Major Players of BIVV-001

Table 6. Major Players of BS-027125

Table 7. Major Players of Concizumab

Table 8. Major Players of CSL-689

Table 9. Major Players of Others

Table 10. Global Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)

Table 11. Global Hemophilia A Drug Sales Market Share by Type (2017-2022)

Table 12. Global Hemophilia A Drug Revenue by Type (2017-2022) & ($ million)

Table 13. Global Hemophilia A Drug Revenue Market Share by Type (2017-2022)

Table 14. Global Hemophilia A Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 15. Global Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)

Table 16. Global Hemophilia A Drug Sales Market Share by Application (2017-2022)

Table 17. Global Hemophilia A Drug Revenue by Application (2017-2022)

Table 18. Global Hemophilia A Drug Revenue Market Share by Application (2017-2022)

Table 19. Global Hemophilia A Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 20. Global Hemophilia A Drug Sales by Company (2020-2022) & (K Pcs)

Table 21. Global Hemophilia A Drug Sales Market Share by Company (2020-2022)

Table 22. Global Hemophilia A Drug Revenue by Company (2020-2022) ($ Millions)

Table 23. Global Hemophilia A Drug Revenue Market Share by Company (2020-2022)

Table 24. Global Hemophilia A Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 25. Key Manufacturers Hemophilia A Drug Producing Area Distribution and Sales Area

Table 26. Players Hemophilia A Drug Products Offered

Table 27. Hemophilia A Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 28. New Products and Potential Entrants

Table 29. Mergers & Acquisitions, Expansion

Table 30. Global Hemophilia A Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 31. Global Hemophilia A Drug Sales Market Share Geographic Region (2017-2022)

Table 32. Global Hemophilia A Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 33. Global Hemophilia A Drug Revenue Market Share by Geographic Region (2017-2022)

Table 34. Global Hemophilia A Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 35. Global Hemophilia A Drug Sales Market Share by Country/Region (2017-2022)

Table 36. Global Hemophilia A Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 37. Global Hemophilia A Drug Revenue Market Share by Country/Region (2017-2022)

Table 38. Americas Hemophilia A Drug Sales by Country (2017-2022) & (K Pcs)

Table 39. Americas Hemophilia A Drug Sales Market Share by Country (2017-2022)

Table 40. Americas Hemophilia A Drug Revenue by Country (2017-2022) & ($ Millions)

Table 41. Americas Hemophilia A Drug Revenue Market Share by Country (2017-2022)

Table 42. Americas Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)

Table 43. Americas Hemophilia A Drug Sales Market Share by Type (2017-2022)

Table 44. Americas Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)

Table 45. Americas Hemophilia A Drug Sales Market Share by Application (2017-2022)

Table 46. APAC Hemophilia A Drug Sales by Region (2017-2022) & (K Pcs)

Table 47. APAC Hemophilia A Drug Sales Market Share by Region (2017-2022)

Table 48. APAC Hemophilia A Drug Revenue by Region (2017-2022) & ($ Millions)

Table 49. APAC Hemophilia A Drug Revenue Market Share by Region (2017-2022)

Table 50. APAC Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)

Table 51. APAC Hemophilia A Drug Sales Market Share by Type (2017-2022)

Table 52. APAC Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)

Table 53. APAC Hemophilia A Drug Sales Market Share by Application (2017-2022)

Table 54. Europe Hemophilia A Drug Sales by Country (2017-2022) & (K Pcs)

Table 55. Europe Hemophilia A Drug Sales Market Share by Country (2017-2022)

Table 56. Europe Hemophilia A Drug Revenue by Country (2017-2022) & ($ Millions)

Table 57. Europe Hemophilia A Drug Revenue Market Share by Country (2017-2022)

Table 58. Europe Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)

Table 59. Europe Hemophilia A Drug Sales Market Share by Type (2017-2022)

Table 60. Europe Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)

Table 61. Europe Hemophilia A Drug Sales Market Share by Application (2017-2022)

Table 62. Middle East & Africa Hemophilia A Drug Sales by Country (2017-2022) & (K Pcs)

Table 63. Middle East & Africa Hemophilia A Drug Sales Market Share by Country (2017-2022)

Table 64. Middle East & Africa Hemophilia A Drug Revenue by Country (2017-2022) & ($ Millions)

Table 65. Middle East & Africa Hemophilia A Drug Revenue Market Share by Country (2017-2022)

Table 66. Middle East & Africa Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Hemophilia A Drug Sales Market Share by Type (2017-2022)

Table 68. Middle East & Africa Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)

Table 69. Middle East & Africa Hemophilia A Drug Sales Market Share by Application (2017-2022)

Table 70. Key Market Drivers & Growth Opportunities of Hemophilia A Drug

Table 71. Key Market Challenges & Risks of Hemophilia A Drug

Table 72. Key Industry Trends of Hemophilia A Drug

Table 73. Hemophilia A Drug Raw Material

Table 74. Key Suppliers of Raw Materials

Table 75. Hemophilia A Drug Distributors List

Table 76. Hemophilia A Drug Customer List

Table 77. Global Hemophilia A Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 78. Global Hemophilia A Drug Sales Market Forecast by Region

Table 79. Global Hemophilia A Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Global Hemophilia A Drug Revenue Market Share Forecast by Region (2023-2028)

Table 81. Americas Hemophilia A Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 82. Americas Hemophilia A Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. APAC Hemophilia A Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 84. APAC Hemophilia A Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 85. Europe Hemophilia A Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Europe Hemophilia A Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Middle East & Africa Hemophilia A Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 88. Middle East & Africa Hemophilia A Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Global Hemophilia A Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 90. Global Hemophilia A Drug Sales Market Share Forecast by Type (2023-2028)

Table 91. Global Hemophilia A Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 92. Global Hemophilia A Drug Revenue Market Share Forecast by Type (2023-2028)

Table 93. Global Hemophilia A Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 94. Global Hemophilia A Drug Sales Market Share Forecast by Application (2023-2028)

Table 95. Global Hemophilia A Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 96. Global Hemophilia A Drug Revenue Market Share Forecast by Application (2023-2028)

Table 97. Bayer AG Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors

Table 98. Bayer AG Hemophilia A Drug Product Offered

Table 99. Bayer AG Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. Bayer AG Main Business

Table 101. Bayer AG Latest Developments

Table 102. BioMarin Pharmaceutical Inc Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors

Table 103. BioMarin Pharmaceutical Inc Hemophilia A Drug Product Offered

Table 104. BioMarin Pharmaceutical Inc Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. BioMarin Pharmaceutical Inc Main Business

Table 106. BioMarin Pharmaceutical Inc Latest Developments

Table 107. Bioverativ Inc Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors

Table 108. Bioverativ Inc Hemophilia A Drug Product Offered

Table 109. Bioverativ Inc Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 110. Bioverativ Inc Main Business

Table 111. Bioverativ Inc Latest Developments

Table 112. Catalyst Biosciences Inc Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors

Table 113. Catalyst Biosciences Inc Hemophilia A Drug Product Offered

Table 114. Catalyst Biosciences Inc Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 115. Catalyst Biosciences Inc Main Business

Table 116. Catalyst Biosciences Inc Latest Developments

Table 117. Chugai Pharmaceutical Co Ltd Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors

Table 118. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product Offered

Table 119. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 120. Chugai Pharmaceutical Co Ltd Main Business

Table 121. Chugai Pharmaceutical Co Ltd Latest Developments

Table 122. CSL Ltd Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors

Table 123. CSL Ltd Hemophilia A Drug Product Offered

Table 124. CSL Ltd Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 125. CSL Ltd Main Business

Table 126. CSL Ltd Latest Developments

Table 127. DBV Technologies SA Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors

Table 128. DBV Technologies SA Hemophilia A Drug Product Offered

Table 129. DBV Technologies SA Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 130. DBV Technologies SA Main Business

Table 131. DBV Technologies SA Latest Developments

Table 132. Dimension Therapeutics Inc Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors

Table 133. Dimension Therapeutics Inc Hemophilia A Drug Product Offered

Table 134. Dimension Therapeutics Inc Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 135. Dimension Therapeutics Inc Main Business

Table 136. Dimension Therapeutics Inc Latest Developments

Table 137. EpiVax Inc Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors

Table 138. EpiVax Inc Hemophilia A Drug Product Offered

Table 139. EpiVax Inc Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 140. EpiVax Inc Main Business

Table 141. EpiVax Inc Latest Developments

Table 142. Expression Therapeutics LLC Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors

Table 143. Expression Therapeutics LLC Hemophilia A Drug Product Offered

Table 144. Expression Therapeutics LLC Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 145. Expression Therapeutics LLC Main Business

Table 146. Expression Therapeutics LLC Latest Developments

Table 147. Green Cross Corp Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors

Table 148. Green Cross Corp Hemophilia A Drug Product Offered

Table 149. Green Cross Corp Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 150. Green Cross Corp Main Business

Table 151. Green Cross Corp Latest Developments

Table 152. Idogen AB Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors

Table 153. Idogen AB Hemophilia A Drug Product Offered

Table 154. Idogen AB Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 155. Idogen AB Main Business

Table 156. Idogen AB Latest Developments

Table 157. Immusoft Corp Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors

Table 158. Immusoft Corp Hemophilia A Drug Product Offered

Table 159. Immusoft Corp Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 160. Immusoft Corp Main Business

Table 161. Immusoft Corp Latest Developments

Table 162. LFB SA Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors

Table 163. LFB SA Hemophilia A Drug Product Offered

Table 164. LFB SA Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 165. LFB SA Main Business

Table 166. LFB SA Latest Developments

Table 167. mAbxience SA Basic Information, Hemophilia A Drug Manufacturing Base, Sales Area and Its Competitors

Table 168. mAbxience SA Hemophilia A Drug Product Offered

Table 169. mAbxience SA Hemophilia A Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 170. mAbxience SA Main Business

Table 171. mAbxience SA Latest Developments

List of Figures

Figure 1. Picture of Hemophilia A Drug

Figure 2. Hemophilia A Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Hemophilia A Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Hemophilia A Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Hemophilia A Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of ATXF-8117

Figure 10. Product Picture of BAY-1093884

Figure 11. Product Picture of BIVV-001

Figure 12. Product Picture of BS-027125

Figure 13. Product Picture of Concizumab

Figure 14. Product Picture of CSL-689

Figure 15. Product Picture of Others

Figure 16. Global Hemophilia A Drug Sales Market Share by Type in 2021

Figure 17. Global Hemophilia A Drug Revenue Market Share by Type (2017-2022)

Figure 18. Hemophilia A Drug Consumed in Clinic

Figure 19. Global Hemophilia A Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 20. Hemophilia A Drug Consumed in Hospital

Figure 21. Global Hemophilia A Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 22. Hemophilia A Drug Consumed in ASCs

Figure 23. Global Hemophilia A Drug Market: ASCs (2017-2022) & (K Pcs)

Figure 24. Global Hemophilia A Drug Sales Market Share by Application (2017-2022)

Figure 25. Global Hemophilia A Drug Revenue Market Share by Application in 2021

Figure 26. Hemophilia A Drug Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Hemophilia A Drug Revenue Market Share by Company in 2021

Figure 28. Global Hemophilia A Drug Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Hemophilia A Drug Revenue Market Share by Geographic Region in 2021

Figure 30. Global Hemophilia A Drug Sales Market Share by Region (2017-2022)

Figure 31. Global Hemophilia A Drug Revenue Market Share by Country/Region in 2021

Figure 32. Americas Hemophilia A Drug Sales 2017-2022 (K Pcs)

Figure 33. Americas Hemophilia A Drug Revenue 2017-2022 ($ Millions)

Figure 34. APAC Hemophilia A Drug Sales 2017-2022 (K Pcs)

Figure 35. APAC Hemophilia A Drug Revenue 2017-2022 ($ Millions)

Figure 36. Europe Hemophilia A Drug Sales 2017-2022 (K Pcs)

Figure 37. Europe Hemophilia A Drug Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Hemophilia A Drug Sales 2017-2022 (K Pcs)

Figure 39. Middle East & Africa Hemophilia A Drug Revenue 2017-2022 ($ Millions)

Figure 40. Americas Hemophilia A Drug Sales Market Share by Country in 2021

Figure 41. Americas Hemophilia A Drug Revenue Market Share by Country in 2021

Figure 42. United States Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Hemophilia A Drug Sales Market Share by Region in 2021

Figure 47. APAC Hemophilia A Drug Revenue Market Share by Regions in 2021

Figure 48. China Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Hemophilia A Drug Sales Market Share by Country in 2021

Figure 55. Europe Hemophilia A Drug Revenue Market Share by Country in 2021

Figure 56. Germany Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Hemophilia A Drug Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Hemophilia A Drug Revenue Market Share by Country in 2021

Figure 63. Egypt Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Hemophilia A Drug Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Hemophilia A Drug in 2021

Figure 69. Manufacturing Process Analysis of Hemophilia A Drug

Figure 70. Industry Chain Structure of Hemophilia A Drug

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles